GLP1R and chronic kidney disease: The current study, emulating a hypothetical clinical trial, reveals significantly lower acute healthcare utilization among a national cohort of patients enrolled at the VHA with moderate to advanced CKD following initiation of GLP1-RA as compared to propensity score matched active comparators.